Farther Finance Advisors’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4 Buy
+1
New +$5 ﹤0.01% 6118
2024
Q3
– Sell
-80
Closed -$94 – 4065
2024
Q2
$94 Buy
+80
New +$132 ﹤0.01% 3609

Other funds holding IMRX

Farther Finance Advisors's IMRX Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Immuneering (IMRX) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #6118 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in IMRX as recently as Q2 2024.

Farther Finance Advisors first reported a position in IMRX in Q2 2024 and has held it in 2 quarters since. The position peaked at $94 in Q2 2024. 2 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • Farther Finance Advisors held 1 share of Immuneering worth $4 as of Q3 2026.
  • Immuneering was a new Farther Finance Advisors position in Q3 2026.
  • Immuneering made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6118 holding.
  • Farther Finance Advisors first reported a position in Immuneering in Q2 2024 and has held it in 2 quarters since.
  • Farther Finance Advisors's Immuneering position peaked at $94 in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.